Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Leukemia

• Publication date

  2014-01-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2013.125PMID 23608884PMCID PMC3806892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia

  2012cited by this paper
• Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.

  2012cited by this paper
• Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

  2011cited by this paper
• Importance of genetics in chronic lymphocytic leukemia.

  2011cited by this paper
• Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

  2011cited by this paper
• miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

  2010cited by this paper
• Fatty acids trigger mitochondrion-dependent necrosis

  2010cited by this paper
• Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

  2010cited by this paper
• Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

  2010cited by this paper
• Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL).

  2010cited by this paper
• Fatty acids trigger mitochondrion-dependent necrosis

  2010cited by this paper
• Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.

  2009cited by this paper
• Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression.

  2009cited by this paper
• Treatment resistance in chronic lymphocytic leukemia–the role of the p53 pathway

  2009cited by this paper
• The first 30 years of p53: growing ever more complex

  2009cited by this paper
• Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

  2008cited by this paper
• Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.

  2008cited by this paper
• Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

  2008cited by this paper
• Noxa: at the tip of the balance between life and death

  2008cited by this paper
• p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter

  2008cited by this paper
• Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

  2007cited by this paper
• Dissecting p53-dependent apoptosis

  2006cited by this paper
• Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

  2006cited by this paper
• Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

  2005cited by this paper
• Biology of osteogenic sarcoma.

  2005cited by this paper
• TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice.

  2004cited by this paper
• APRIL promotes B-1 cell-associated neoplasm.

  2004cited by this paper
• Brief DeHnitive Report

  2003cited by this paper
• Inhibition of Mitochondrial Respiration

  2003cited by this paper
• Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

  2002cited by this paper
• Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

  2000cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• Cancer statistics, 1998

  1998cited by this paper
• p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis.

  1998cited by this paper
• Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome.

  1996cited by this paper
• The role of p53 in cell-cycle control and apoptosis: implications for cancer.

  1995cited by this paper
• p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.

  1995cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Mutational spectra and immunohistochemical analyses of p53 in human cancers.

  1992cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

  1988cited by this paper

• A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia

  2025cites this paper
• The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia.

  2025cites this paper
• BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism

  2024cites this paper
• Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer.

  2024cites this paper
• Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state

  2023cites this paper
• Prostate cancer and microRNAs: New insights into apoptosis.

  2023cites this paper
• miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.

  2023cites this paper
• Dual role of microRNAs in cancer metastasis

  2023cites this paper
• Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas

  2022cites this paper
• Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice

  2022cites this paper
• Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells

  2022cites this paper
• Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations

  2022cites this paper
• B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia

  2022cites this paper
• Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression

  2021cites this paper
• Co-delivery of miRNA-15a and miRNA-16–1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells

  2021cites this paper
• miRNAs Mediated Drug Resistance in Hematological Malignancies.

  2021cites this paper
• Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

  2021cites this paper
• MicroRNA-16 participates in the cell cycle alteration of HepG2 cells induced by MC-LR.

  2020cites this paper
• The Role of Noncoding RNAs in B-Cell Lymphoma

  2020cites this paper
• Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis

  2020cites this paper
• Small RNAs, Big Diseases

  2020cites this paper
• Amino Acid Metabolism in Hematologic Malignancies and the Era of Targeted Therapy.

  2019cites this paper
• How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor

  2019cites this paper
• MiR-16 regulates crosstalk in NF-kB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages.

  2019cites this paper
• MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy

  2018cites this paper
• The miR‐15a/16 gene cluster in human cancer: A systematic review

  2018cites this paper
• Functions and epigenetic aspects of miR-15/16: Possible future cancer therapeutics

  2018cites this paper
• Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia

  2017cites this paper
• Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts

  2017cites this paper
• MicroRNA16 regulates glioma cell proliferation, apoptosis and invasion by targeting Wip1-ATM-p53 feedback loop

  2017cites this paper
• A Looking-Glass of Non-Coding RNAs in Oral Cancer

  2017cites this paper
• Post-transcriptional Mechanisms in Endocrine Regulation

  2016cites this paper
• Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53.

  2016cites this paper
• Elimination of Chronic Lymphocytic Leukemia Cells in Stromal Microenvironment by Targeting CPT with an Anti-Angina Drug Perhexiline

  2016cites this paper
• Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism

  2016cites this paper
• Systemic depletion of serum l-Cyst(e)ine with an engineered human enzyme induces production of reactive oxygen species and suppresses tumor growth in mice

  2016cites this paper
• c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia

  2016cites this paper
• TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia

  2016cites this paper
• Post-transcriptional Regulation of Prostaglandin Biosynthesis

  2016cites this paper
• Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth

  2016cites this paper
• The long journey of TCL1 transgenic mice: lessons learned in the last 15 years.

  2015cites this paper
• Targeting ATM-deficient CLL through interference with DNA repair pathways

  2015cites this paper
• Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.

  2015cites this paper
• miRNA-15a/16: as tumor suppressors and more.

  2015cites this paper
• Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin

  2015cites this paper
• miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer

  2015cites this paper
• Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.

  2015cites this paper
• TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia

  2015cites this paper
• Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.

  2014cites this paper
• Review Article Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma

  2014cites this paper
• Inhibidors de cinases com a estratègia terapèutica en neoplàsies limfoides

  2014cites this paper
• de Sousa Regulation of MCL 1 alternative polyadenylation-derived mRNA isoforms by microRNAs in human T cells

  2014cites this paper
• Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia

  2014cites this paper
• Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy.

  2014cites this paper
• A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53

  2014cites this paper
• Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p.

  2014cites this paper
• Murine genetically engineered and human xenograft models of chronic lymphocytic leukemia.

  2014cites this paper
• PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model

  2014cites this paper
• ROR1 can interact with TCL1 and enhance leukemogenesis in Eµ-TCL1 transgenic mice

  2013cites this paper
• A role for IRF4 in the development of CLL.

  2013cites this paper